Cathie Wood’s ARK Invest Buys Over 1.5 Million Shares of Allogene

One ARK Invest exchange-traded fund run by ETF star Cathie Wood bought over 1.5 million shares of Allogene Therapeutics Inc. (NASDAQ: ALLO) on Tuesday. The price of this ETF was down more than 1% in Tuesday’s session, and it is down a fair amount in the past year.

It was the ARK Genomic Revolution ETF (NYSEARCA: ARKG) that added 1,581,099 shares of Allogene. At Tuesday’s closing price, this would have valued this purchase at roughly $22.6 million. This is only a small fraction of the total holdings. The ETF is down roughly 37% in the past year.

Check out all of ARK Invest’s buys for Tuesday:

FundTickerNameShares
ARKFAMZNAMAZON.COM71
ARKFPINSPINTEREST50
ARKFPAGSPAGSEGURO DIGITAL15,747
ARKFFBFACEBOOK624
ARKGPFEPFIZER80,672
ARKGALLOALLOGENE THERAPEUTICS1,581,099
ARKGREGNREGENERON PHARMACEUTICALS4,092
ARKKIOVAIOVANCE BIOTHERAPEUTICS167,635
ARKKEDITEDITAS MEDICINE220,037
ARKKPRLBPROTO LABS196
ARKQJDJD.COM56,925
ARKWZZILLOW1,304
ARKWSHOPSHOPIFY1,914
ARKWLPSNLIVEPERSON203,247
ARKWFTCHFARFETCH1,582
ARKWFBFACEBOOK1,973
ARKXBABOEING141
ARKXHOFPTHALES46,027

Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.

Source: Read Full Article